Stay updated on Pembrolizumab Combo in ES-SCLC 2nd-line Therapy Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo in ES-SCLC 2nd-line Therapy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo in ES-SCLC 2nd-line Therapy Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Added September 2025 release notes (Revision: v3.0.2) and removed August 2025 notes (Revision: v3.0.1) plus the Back to Top link.
    Difference
    0.4%
    Check dated 2025-09-14T22:07:09.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new version, v3.0.1, indicating a recent revision. The previous version, v3.0.0, has been removed from the page.
    Difference
    0.1%
    Check dated 2025-09-07T19:12:17.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The webpage has been updated to include new facility names and locations, as well as additional drug information for Lenvatinib and Pembrolizumab. Some outdated information has been removed, including previous location details and older drug information.
    Difference
    12%
    Check dated 2025-08-31T12:22:00.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    33 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.0%
    Check dated 2025-08-17T04:50:42.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.10 to version 2.16.11.
    Difference
    0.0%
    Check dated 2025-08-10T00:42:33.000Z thumbnail image
  7. Check
    47 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.
    Difference
    0.6%
    Check dated 2025-08-02T19:34:53.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo in ES-SCLC 2nd-line Therapy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in ES-SCLC 2nd-line Therapy Clinical Trial page.